Fingerprint
Dive into the research topics of 'Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc1 inhibition strategy for malaria'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc1 inhibition strategy for malaria
Allison M. Stickles, Martin J. Smilkstein, Joanne M. Morrisey, Yuexin Li, Isaac P. Forquer, Jane X. Kelly, Sovitj Pou, Rolf W. Winter, Aaron Nilsen, Akhil B. Vaidya, Michael K. Riscoe
Research output: Contribution to journal › Article › peer-review
45
Scopus
citations